作者
- Clark, A.L. (10)
- Cleland, J.G.F. (22)
- Di Lenarda, A. (4)
- Hanrath, P. (4)
- McMurray, J.J.V. (4)
- Metra, M. (6)
- Poole-Wilson, P.A. (7)
- Rigby, A.S. (4)
- Swedberg, K. (6)
- Witte, K.K.A. (5)
|
總筆數:22
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Reliability of reporting left ventricular systolic function byechocardiography: A systematic review of 3 methods |
McGowan, J.H.;Cleland, J.G.F.; |
American Heart Journal |
2003-09-01 |
查看 |
| Are hematinic deficiencies the cause of anemia in chronic heart failure? |
Witte, K.K.A.;Desilva, R.;Chattopadhyay, S.;Ghosh, J.;Cleland, J.G.F.;Clark, A.L.; |
American Heart Journal |
2004-05-01 |
查看 |
| Are hematinic deficiencies the cause of anemia in chronic heart failure? |
Witte, K.K.A.;Desilva, R.;Chattopadhyay, S.;Ghosh, J.;Cleland, J.G.F.;Clark, A.L.; |
American Heart Journal |
2004-05-01 |
查看 |
| Are hematinic deficiencies the cause of anemia in chronic heart failure? |
Witte, K.K.A.;Desilva, R.;Chattopadhyay, S.;Ghosh, J.;Cleland, J.G.F.;Clark, A.L.; |
American Heart Journal |
2004-05-01 |
查看 |
| The Warfarin/Aspirin study in heart failure (WASH): a randomized trialcomparing antithrombotic strategies for patients with heart failure |
Cleland, J.G.F.;Findlay, I.;Jafri, S.;Sutton, G.;Falk, R.;Bulpitt, C.;Prentice, C.;Ford, I.;Trainer, A.;Poole-Wilson, P.A.; |
American Heart Journal |
2004-07-01 |
查看 |
| The Warfarin/Aspirin study in heart failure (WASH): a randomized trialcomparing antithrombotic strategies for patients with heart failure |
Cleland, J.G.F.;Findlay, I.;Jafri, S.;Sutton, G.;Falk, R.;Bulpitt, C.;Prentice, C.;Ford, I.;Trainer, A.;Poole-Wilson, P.A.; |
American Heart Journal |
2004-07-01 |
查看 |
| The Warfarin/Aspirin study in heart failure (WASH): a randomized trialcomparing antithrombotic strategies for patients with heart failure |
Cleland, J.G.F.;Findlay, I.;Jafri, S.;Sutton, G.;Falk, R.;Bulpitt, C.;Prentice, C.;Ford, I.;Trainer, A.;Poole-Wilson, P.A.; |
American Heart Journal |
2004-07-01 |
查看 |
| Effects of metoprolol and carvedilol on cause-specific mortality andmorbidity in patients with chronic heart failure-COMET |
Torp-Pedersen, C.;Poole-Wilson, P.A.;Swedberg, K.;Cleland, J.G.F.;Di Lenarda, A.;Hanrath, P.;Komajda, M.;Lutiger, B.;Metra, M.;Remme, W.J.;Scherhag, A.;Skene, A.;for the COMET Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Effects of metoprolol and carvedilol on cause-specific mortality andmorbidity in patients with chronic heart failure-COMET |
Torp-Pedersen, C.;Poole-Wilson, P.A.;Swedberg, K.;Cleland, J.G.F.;Di Lenarda, A.;Hanrath, P.;Komajda, M.;Lutiger, B.;Metra, M.;Remme, W.J.;Scherhag, A.;Skene, A.;for the COMET Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Effects of metoprolol and carvedilol on cause-specific mortality andmorbidity in patients with chronic heart failure-COMET |
Torp-Pedersen, C.;Poole-Wilson, P.A.;Swedberg, K.;Cleland, J.G.F.;Di Lenarda, A.;Hanrath, P.;Komajda, M.;Lutiger, B.;Metra, M.;Remme, W.J.;Scherhag, A.;Skene, A.;for the COMET Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Effects of metoprolol and carvedilol on cause-specific mortality andmorbidity in patients with chronic heart failure-COMET |
for the COMET Investigators;Torp-Pedersen, C.;Poole-Wilson, P.A.;Swedberg, K.;Cleland, J.G.F.;Di Lenarda, A.;Hanrath, P.;Komajda, M.;Lutiger, B.;Metra, M.;Remme, W.J.;Scherhag, A.;Skene, A.; |
American Heart Journal |
2005-02-01 |
查看 |
| Tezosentan in patients with acute heart failure: Design of the Value ofEndothelin Receptor Inhibition with Tezosentan in Acute heart failure Study(VERITAS) |
VERITAS Investigators;Teerlink, J.R.;McMurray, J.J.V.;Bourge, R.C.;Cleland, J.G.F.;Cotter, G.;Jondeau, G.;Krum, H.;Metra, M.;O'Connor, C.M.;Parker, J.D.;Torre-Amione, G.;Van Veldhuisen, D.J.;Frey, A.;Rainisio, M.;Kobrin, I.; |
American Heart Journal |
2005-07-01 |
查看 |
| Tezosentan in patients with acute heart failure: Design of the Value ofEndothelin Receptor Inhibition with Tezosentan in Acute heart failure Study(VERITAS) |
VERITAS Investigators;Teerlink, J.R.;McMurray, J.J.V.;Bourge, R.C.;Cleland, J.G.F.;Cotter, G.;Jondeau, G.;Krum, H.;Metra, M.;O'Connor, C.M.;Parker, J.D.;Torre-Amione, G.;Van Veldhuisen, D.J.;Frey, A.;Rainisio, M.;Kobrin, I.; |
American Heart Journal |
2005-07-01 |
查看 |
| The effect of altering heart rate on ventricular function in patientswith heart failure treated with @b-blockers |
Thackray, S.D.R.;Ghosh, J.M.;Wright, G.A.;Witte, K.K.A.;Nikitin, N.P.;Kaye, G.C.;Clark, A.L.;Tweddel, A.;Cleland, J.G.F.; |
American Heart Journal |
2006-10-01 |
查看 |
| The effect of altering heart rate on ventricular function in patientswith heart failure treated with @b-blockers |
Thackray, S.D.R.;Ghosh, J.M.;Wright, G.A.;Witte, K.K.A.;Nikitin, N.P.;Kaye, G.C.;Clark, A.L.;Tweddel, A.;Cleland, J.G.F.; |
American Heart Journal |
2006-10-01 |
查看 |
| The effects of initiation or continuation of statin therapy oncholesterol level and all-cause mortality after the diagnosis of leftventricular systolic dysfunction |
Huan Loh, P.;Windram, J.D.;Tin, L.;Reddy, P.;Velavan, P.;Rigby, A.S.;Atkin, P.;Nikitin, N.P.;Clark, A.L.;Cleland, J.G.F.; |
American Heart Journal |
2007-04-01 |
查看 |
| Relationship of high-sensitivity C-reactive protein to prognosis andother prognostic markers in outpatients with heart failure |
Windram, J.D.;Loh, P.H.;Rigby, A.S.;Hanning, I.;Clark, A.L.;Cleland, J.G.F.; |
American Heart Journal |
2007-06-01 |
查看 |
| Relationship of high sensitivity C reactive peptide (hsCRP) toprognosis and other prognostic markers in outpatients with heart failure |
Windram, J.D.;Loh, P.H.;Rigby, A.S.;Clark, A.L.;Cleland, J.G.F.; |
American Heart Journal |
2008-02-01 |
查看 |
| Relationship of high sensitivity C reactive peptide (hsCRP) toprognosis and other prognostic markers in outpatients with heart failure |
Windram, J.D.;Loh, P.H.;Rigby, A.S.;Clark, A.L.;Cleland, J.G.F.; |
American Heart Journal |
2008-02-01 |
查看 |
| Days alive and out of hospital and the patient journey in patients withheart failure: Insights from the Candesartan in Heart failure: Assessmentof Reduction in Mortality and morbidity (CHARM) program |
Ariti, C.A.;Cleland, J.G.F.;Pocock, S.J.;Pfeffer, M.A.;Swedberg, K.;Granger, C.B.;McMurray, J.J.V.;Michelson, E.L.;Ostergren, J.;Yusuf, S.; |
American Heart Journal |
2011-11-01 |
查看 |
| Days alive and out of hospital and the patient journey in patients withheart failure: Insights from the Candesartan in Heart failure: Assessmentof Reduction in Mortality and morbidity (CHARM) program |
Ariti, C.A.;Cleland, J.G.F.;Pocock, S.J.;Pfeffer, M.A.;Swedberg, K.;Granger, C.B.;McMurray, J.J.V.;Michelson, E.L.;Ostergren, J.;Yusuf, S.; |
American Heart Journal |
2011-11-01 |
查看 |
| Minimally clinically important difference in chronic breathlessness:Every little helps |
Oxberry, S.G.;Bland, J.M.;Clark, A.L.;Cleland, J.G.F.;Johnson, M.J.; |
American Heart Journal |
2012-08-01 |
查看 |
|
|
|
